These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2603509)

  • 1. [Side effects caused by ofloxacin: status of knowledge before legalization and changes caused by spontaneous reports thereafter].
    Esch B; Paeschke N; Christ W; Kreutz G
    Verh Dtsch Ges Inn Med; 1989; 95():717-21. PubMed ID: 2603509
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview of postmarketing experience with ofloxacin in Germany.
    Jüngst G; Mohr R
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():167-75. PubMed ID: 3053577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects caused by benzodiazepines and sedating neuroleptics--results of comprehensive hospital drug monitoring].
    Blatter M; Maurer P; Maibach R; Hoigné R; Hess T; Galeazzi R; Knoblauch A; Rohrer J; Jordi A
    Verh Dtsch Ges Inn Med; 1989; 95():699-704. PubMed ID: 2574926
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase IV study and post-marketing surveillance of ofloxacin in Japan.
    Sawada M; Nakamura S; Yamada A; Kobayashi T; Okada S
    Chemotherapy; 1991; 37(2):134-42. PubMed ID: 2032469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of ofloxacin in clinical trials and in postmarketing surveillance.
    Jüngst G; Mohr R
    Drugs; 1987; 34 Suppl 1():144-9. PubMed ID: 3325257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levofloxacin adverse effects, data from clinical trials and pharmacovigilance].
    Carbon C
    Therapie; 2001; 56(1):35-40. PubMed ID: 11322015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
    Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
    Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric side effects of ofloxacin used in the treatment of pelvic inflammatory disease.
    Hall CE; Keegan H; Rogstad KE
    Int J STD AIDS; 2003 Sep; 14(9):636-7. PubMed ID: 14511503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postmarketing surveillance studies in community pharmacies].
    Nieber K; Lehmacher W
    Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmarketing surveillance on side-effects of cefminox sodium (Meicelin).
    Mayama T; Koyama Y; Sebata K; Tanaka Y; Shirai S; Sakai H
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):149-55. PubMed ID: 7599913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudomembranous colitis caused by ofloxacin].
    Gineston JL; Reix N; Andrejak M; Capron JP
    Gastroenterol Clin Biol; 1989; 13(8-9):745. PubMed ID: 2806809
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of ofloxacin.
    Tack KJ; Smith JA
    Am J Med; 1989 Dec; 87(6C):78S-81S. PubMed ID: 2690623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing surveillance of food additives.
    Butchko HH; Tschanz C; Kotsonis FN
    Regul Toxicol Pharmacol; 1994 Aug; 20(1 Pt 1):105-18. PubMed ID: 7838988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing surveillance for oncology drugs.
    Viale PH; Moore S
    Clin J Oncol Nurs; 2008 Dec; 12(6):877-86. PubMed ID: 19064381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected role of ofloxacin in a case of arthalgia, myalgia, and multiple tendinopathy.
    Schwald N; Debray-Meignan S
    Rev Rhum Engl Ed; 1999; 66(7-9):419-21. PubMed ID: 10526383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing experience with auranofin in the Federal Republic of Germany.
    Schattenkirchner M; Missler B; Mulz D
    Scand J Rheumatol Suppl; 1986; 63():57-66. PubMed ID: 3299683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions: a review of relevant factors.
    Ajayi FO; Sun H; Perry J
    J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of levofloxacin.
    Prescrire Int; 2002 Aug; 11(60):116-7. PubMed ID: 12199267
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of different logistical approaches to postmarketing surveillance.
    Strom BL
    J Rheumatol Suppl; 1988 Oct; 17():9-13. PubMed ID: 3204621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.